An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.

Published

Other Article

Full Text

Duke Authors

Cited Authors

  • Parker, W; Berek, JS; Pritts, E; Olive, D; Kaunitz, AM; Chalas, E; Clarke-Pearson, D; Goff, B; Bristow, R; Taylor, HS; Farias-Eisner, R; Fader, AN; Maxwell, GL; Goodwin, SC; Love, S; Gibbons, WE; Foshag, LJ; Leppert, PC; Norsigian, J; Nager, CW; Johnson, T; Guzick, DS; As-Sanie, S; Paulson, RJ; Farquhar, C; Bradley, L; Scheib, SA; Bilchik, AJ; Rice, LW; Dionne, C; Jacoby, A; Ascher-Walsh, C; Kilpatrick, SJ; Adamson, GD; Siedhoff, M; Israel, R; Paraiso, MF; Frumovitz, MM; Lurain, JR; Al-Hendy, A; Benrubi, GI; Raman, SS; Kho, RM; Anderson, TL; Reynolds, RK; DeLancey, J

Published Date

  • March 2016

Published In

Volume / Issue

  • 23 / 3

Start / End Page

  • 303 - 308

PubMed ID

  • 26773577

Pubmed Central ID

  • 26773577

Electronic International Standard Serial Number (EISSN)

  • 1553-4669

Digital Object Identifier (DOI)

  • 10.1016/j.jmig.2015.12.012

Language

  • eng

Conference Location

  • United States